Two postdoctoral fellow positions are immediately available for highly motivated scientists to investigate how post-translational modification signaling, metabolic pathways, and immune system intertwine to mediate tumor metastasis and therapy resistance in human cancers. Our research focuses on translational and preclinical studies of human cancers using multidisciplinary approaches including proteomics, metabolomics, transcriptomics, and drug discovery, with ultimate goals to develop targeted therapeutic strategies to treat human cancers. For some of the related work of our laboratory please see Nat Commun (2021) 12:4960, J Clin Invest  (2019) 129:2431-45, J Clin Invest  (2019) 129:4110-23, Cancer Cell  (2018) 34:315-30, Mol Cell (2018) 69:87-99, Cancer Cell (2015) 27:257-70. Successful candidates must hold a doctoral-level degree with solid background of biochemistry, molecular and cellular biology, genetics and signal transduction. Experience with animal models of human diseases such as xenograft tumor models is desirable. Applicants should send a CV including the names and contact information of three references to:

Sumin Kang, Ph.D., Professor of Hematology and Medical Oncology

Winship Cancer Institute, Emory University

1365-C Clifton Rd. NE, C-3006

Atlanta, GA 30322

smkang@emory.edu

E-mail: smkang@emory.edu